LIST OF TABLES
TABLE 01. GLOBAL HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 02. CHEMOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 20172025 ($MILLION)
TABLE 03. IMMUNOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 20172025 ($MILLION)
TABLE 04. TARGETED THERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 20172025 ($MILLION)
TABLE 05. GLOBAL HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 06. HEAD & NECK CANCER DRUGS MARKET FOR HOSPITAL PHARMACY, BY REGION, 20172025 ($MILLION)
TABLE 07. HEAD & NECK CANCER DRUGS MARKET FOR ONLINE PROVIDERS, BY REGION, 20172025 ($MILLION)
TABLE 08. HEAD & NECK CANCER DRUGS MARKET FOR DRUG STORES & RETAIL PHARMACIES, BY REGION, 20172025 ($MILLION)
TABLE 09. HEAD & NECK CANCER DRUGS MARKET REVENUE, BY REGION, 20172025 ($MILLION)
TABLE 10. NORTH AMERICA HEAD & NECK CANCER DRUGS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 11. U.S. HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 12. U.S. HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 13. CANADA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 14. CANADA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 15. MEXICO HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 16. MEXICO HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 17. NORTH AMERICA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 18. NORTH AMERICA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 19. EUROPE HEAD & NECK CANCER DRUGS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 20. GERMANY HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 21. GERMANY HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 22. FRANCE HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 23. FRANCE HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 24. UK HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 25. UK HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 26. ITALY HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 27. ITALY HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 28. SPAIN HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 29. SPAIN HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 30. REST OF EUROPE HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 31. REST OF EUROPE HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 32. EUROPE HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 33. EUROPE HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 34. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 35. JAPAN HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 36. JAPAN HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 37. CHINA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 38. CHINA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 39. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 40. AUSTRALIA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 41. INDIA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 42. INDIA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 43. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 44. SOUTH KOREA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 45. REST OF ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 46. REST OF ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 47. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 48. ASIA-PACIFIC HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 49. LAMEA HEAD & NECK CANCER DRUGS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 50. BRAZIL HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 51. BRAZIL HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 52. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 53. SAUDI ARABIA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 54. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 55. SOUTH AFRICA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 56. REST OF LAMEA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 57. REST OF LAMEA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 58. LAMEA HEAD & NECK CANCER DRUGS MARKET, BY DRUG CLASS, 20172025 ($MILLION)
TABLE 59. LAMEA HEAD & NECK CANCER DRUGS MARKET, BY SALES CHANNEL, 20172025 ($MILLION)
TABLE 60. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 61. ASTRAZENECA: OPERATING SEGMENTS
TABLE 62. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 63. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
TABLE 64. BRISTOL-MYERS SQUIBB: PRODUCT PORTFOLIO
TABLE 65. LILLY: COMPANY SNAPSHOT
TABLE 66. LILLY: OPERATING SEGMENTS
TABLE 67. LILLY: PRODUCT PORTFOLIO
TABLE 68. ROCHE: COMPANY SNAPSHOT
TABLE 69. ROCHE: OPERATING SEGMENTS
TABLE 70. ROCHE: PRODUCT PORTFOLIO
TABLE 71. FRESENIUS MEDICAL CARE: COMPANY SNAPSHOT
TABLE 72. FRESENIUS MEDICAL CARE: OPERATING SEGMENTS
TABLE 73. FRESENIUS MEDICAL CARE: PRODUCT PORTFOLIO
TABLE 74. MERCK: COMPANY SNAPSHOT
TABLE 75. MERCK: OPERATING SEGMENTS
TABLE 76. MERCK: PRODUCT PORTFOLIO
TABLE 77. PFIZER: COMPANY SNAPSHOT
TABLE 78. PFIZER: OPERATING SEGMENTS
TABLE 79. PFIZER: PRODUCT PORTFOLIO
TABLE 80. SANOFI: COMPANY SNAPSHOT
TABLE 81. SANOFI: OPERATING SEGMENTS
TABLE 82. SANOFI: PRODUCT PORTFOLIO
TABLE 83. SUN PHARMA: COMPANY SNAPSHOT
TABLE 84. SUN PHARMA: OPERATING SEGMENTS
TABLE 85. SUN PHARMA: PRODUCT PORTFOLIO
TABLE 86. TEVA: COMPANY SNAPSHOT
TABLE 87. TEVA: OPERATING SEGMENTS
TABLE 88. TEVA: PRODUCT PORTFOLIO LIST OF FIGURES
FIGURE 01. HEAD & NECK CANCER DRUGS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS IN THE GLOBAL HEAD & NECK CANCER DRUGS MARKET
FIGURE 03. TOP PLAYER POSITIONING, 2017
FIGURE 04. WORLD POPULATION AGED 65 AND OVER (%)
FIGURE 05. IMPACT ANALYSES, HEAD AND NECK CANCER DRUG MARKET
FIGURE 06. COMPARATIVE COUNTRY ANALYSIS OF CHEMOTHERAPY MARKET FOR HEAD & NECK CANCER, 2017 AND 2025 ($MILLION)
FIGURE 07. COMPARATIVE COUNTRY ANALYSIS OF IMMUNOTHERAPY MARKET FOR HEAD & NECK CANCER, 2017 AND 2025 ($MILLION)
FIGURE 08. COMPARATIVE COUNTRY ANALYSIS OF TARGETED THERAPY MARKET FOR HEAD & NECK CANCER, 2017 AND 2025 ($MILLION)
FIGURE 09. COMPARATIVE COUNTRY ANALYSIS HEAD & NECK CANCER DRUGS MARKET FOR HOSPITAL PHARMACY, 2017 AND 2025 ($MILLION)
FIGURE 10. COMPARATIVE COUNTRY ANALYSIS HEAD & NECK CANCER DRUGS MARKET FOR ONLINE PROVIDERS, 2017 AND 2025 ($MILLION)
FIGURE 11. COMPARATIVE COUNTRY ANALYSIS HEAD & NECK CANCER DRUGS MARKET FOR DRUG STORES & RETAIL PHARMACIES, 2017 AND 2025 ($MILLION)
FIGURE 12. ASTRAZENECA: REVENUE, 20152017 ($MILLION)
FIGURE 13. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 14. REVENUE, 20152017 ($MILLION)
FIGURE 15. BRISTOL-MYERS SQUIBB: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 16. REVENUE, 20152017 ($MILLION)
FIGURE 17. LILLY: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 18. LILLY: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 19. ROCHE: NET SALES, 20152017 ($MILLION)
FIGURE 20. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 21. ROCHE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 22. FRESENIUS MEDICAL CARE: NET SALES, 20152017 ($MILLION)
FIGURE 23. FRESENIUS MEDICAL CARE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 24. MERCK: NET SALES, 20152017 ($MILLION)
FIGURE 25. MERCK: NET SALES BY SEGMENT, 2017 (%)
FIGURE 26. MERCK: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 27. PFIZER: REVENUE, 20152017 ($MILLION)
FIGURE 28. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 29. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 30. SANOFI: NET SALES, 20152017 ($MILLION)
FIGURE 31. SANOFI: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 32. SANOFI: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. SUN PHARMA: NET SALES, 20152017 ($MILLION)
FIGURE 34. SUN PHARMA: NET SALES BY SEGMENT, 2017 (%)
FIGURE 35. TEVA: REVENUE, 20152017 ($MILLION)
FIGURE 36. TEVA: REVENUE BY SEGMENT, 2017 (%)
FIGURE 37. TEVA: REVENUE SHARE BY GEOGRAPHY, 2017 (%